Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A primer on drug utilization review

R T Kubacka1

  • 1University of Pittsburgh School of Pharmacy, Pittsburgh, USA.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|April 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of aspirin and ibuprofen on the pharmacokinetics and pharmacodynamics of glyburide in healthy subjects.

The Annals of pharmacotherapy·1996
Same author

Practical approaches to the management of migraine.

American pharmacy·1994
Same author

Pharmacokinetics and pharmacodynamics of glyburide in young and elderly nondiabetic adults.

Clinical pharmacy·1991
Same author

Educating the educator--implications for psychiatric pharmacy.

Journal of clinical pharmacy and therapeutics·1989
Same author

The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics.

British journal of clinical pharmacology·1987
Same author

Attitudes of patients with hypertension or arthritis toward the frequency of medication administration.

American journal of hospital pharmacy·1985
Same journal

The Sky is His Wife (2001)/Jim Alford (b. 1943).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Zada Mary cooper (1875-1961).

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Aiming for, believing in, and achieving a target a1c of less than 7.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Evaluation of OTC Product Information in Three Drug Information Databases for PDAs.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

New biotechnology approvals for 2002.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
Same journal

Preventing meningococcal outbreaks: an opportunity for pharmacists.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2013
See all related articles

Drug utilization reviews improve patient care and reduce costs. These programs, including Drug Regimen Review and Drug Utilization Review (DUR), decrease medication errors and inappropriate drug use.

Area of Science:

  • Health Services Research
  • Pharmacoeconomics
  • Patient Safety

Background:

  • Healthcare organizations evaluate drug utilization to enhance patient care, control pharmaceutical spending, and improve therapeutic results.
  • Historical initiatives like the Drug Regimen Review (1974) and Drug Usage Evaluation have aimed to optimize medication management.
  • The Omnibus Budget Reconciliation Act of 1990 (OBRA '90) mandated the Drug Utilization Review (DUR) for state Medicaid programs.

Observation:

  • The Drug Regimen Review has demonstrated success in reducing medication use, errors, adverse drug reactions, and drug-drug interactions.
  • Drug Usage Evaluations involve sophisticated analysis of drug use and patient outcomes.
  • Pharmacists conducting DURs are responsible for reviewing drug misuse patterns, monitoring current treatments, and providing patient counseling.

Related Experiment Videos

Findings:

  • Drug utilization reviews have been effective in reducing inappropriate drug consumption.
  • These reviews contribute to significant decreases in overall drug expenditures.
  • The implementation of DUR has led to measurable improvements in medication safety and cost-effectiveness.

Implications:

  • Drug utilization review programs are crucial for quality assurance in healthcare.
  • Optimizing drug use through reviews can lead to better patient outcomes and reduced healthcare costs.
  • Pharmacist-led interventions, such as DUR, play a vital role in evidence-based medication management and public health.